Aller au contenu

514 606-3350

info@cliniqueomicron.ca​

FR / EN
Logo - Clinique Omicron
Pinguecula: Benign Conjunctival Lesion, Causes, and Treatment | Clinique Omicron
Ophthalmology & Family Medicine

Pinguecula

Pinguecula - from Latin fat meaning fatty or oily, in reference to its slightly raised yellowish appearance - is a benign degenerative lesion of the bulbar conjunctiva, characterized by a localized deposition of modified elastic and hyaline connective tissue in the conjunctival stroma of the interpalpebral zone (the portion of conjunctiva exposed to the environment when the eyelids are open), located almost exclusively on the nasal or temporal side of the limbus - at the junction between conjunctiva and cornea - without ever invading the latter, which fundamentally distinguishes it from pterygium. Histologically, pinguecula is characterized by elastoid degeneration of the stromal collagen (accumulation of abnormal elastic fibers called elastoid material) and by calcium and lipid deposits in the superficial layers - the overlying conjunctival epithelium may be thinned or hyperplastic. It results from chronic exposure to irritating environmental factors - mainly ultraviolet radiation (UV-B), wind, dust and dryness - which induce fibroblastic degeneration and progressive accumulation of abnormal extracellular material in the conjunctival stroma. Extremely common in the world's adult population - with prevalence increasing with age and UV exposure - pinguecula is above all a cosmetic lesion and an occasional source of discomfort (sensation of a foreign body + local redness during episodes of pingueculitis), but without any consequences for vision or risk of malignant degeneration, unlike pterygium or neoplasia of the ocular surface. Its easy clinical recognition by the general practitioner or optician avoids unnecessary investigation and reassures the patient that the lesion is benign.

Clinical Presentation and Characteristics

  • Macroscopic aspect yellowish or whitish elevation + slightly raised + triangular or ovoid in shape + with a smooth or slightly granular surface + located on the bulbar conjunctiva in the interpalpebral fissure + nasal side predominant (increased UV exposure on the nasal side due to the concentration effect of UV rays on the nasal limbus via the cornea) + bilateral in 50–60 % of cases + NEVER invades the cornea (key differential criterion with pterygium)
  • Usual symptoms: often asymptomatic + incidentally discovered during a routine eye exam + mild foreign body sensation + intermittent discomfort or irritation + localized dry eye (the pinguecula disrupts the tear film by creating a surface irregularity) + conjunctival redness localized to the site of the lesion
  • Pinguecula acute inflammatory episode of pinguecula → intense localized redness + irritation + tearing + burning sensation + mild pain → triggered by intense sun exposure + wind + dust + prolonged contact lens wear + fatigue + allergy + treatment: artificial tears + anti-inflammatory eye drops (topical NSAID or short-term topical corticosteroid)
  • Evolution Generally stable for years + slow and progressive growth over time + can increase in size with age and accumulation of UV exposure + never degenerates into a malignant lesion + can theoretically evolve into a pterygium (corneal invasion) in rare cases if chronic intense unprotected UV exposure

Differential diagnosis — do not confuse with

Lesion Differences with pinguecula Procedure
Pterygium Invades the cornea (crosses the limbus) → butterfly wing appearance + vascular membrane + can cause irregular astigmatism and vision loss if the optical axis is affected + pingueculae NEVER invade the cornea Reference in ophthalmology: If pterygium progresses towards the visual axis or causes vision loss → surgical excision with autologous conjunctival graft
Ocular Surface Squamous Neoplasia (OSSN — Squamous Cell Carcinoma) Gelatinous lesion + leucoplakic + vascular + rapidly growing + irregular + sometimes pigmented + can invade the cornea + intrinsic vascularization + in immunocompromised patients (HIV) or those exposed to intense UV + biopsy essential if in doubt Biopsy + pathological examination + urgent ophthalmology referral + treatment: excision + topical mitomycin C + or interferon alpha-2b
Conjunctival cyst Translucent lesion + cystic + liquid content + mobile on palpation + without yellowish deposit + often post-traumatic or post-infectious Observation if asymptomatic + excision if bothersome
Conjunctival calcification (conjunctivolithiasis) White calcareous deposits + multiple + small + in the tarsal conjunctiva (inner eyelid surface) + intense foreign body sensation + treatment by superficial ablation Ablation under local anesthesia if symptomatic
Ocular melanosis / Conjunctival nevi Pigmented lesions (brown + black) + acquired melanosis that can degenerate → regular monitoring + biopsy if growth or color change Annual photographic surveillance in ophthalmology + biopsy if melanoma is suspected.

Risk factors

  • UV radiation exposure: Primary risk factors: people working outdoors (farmers, sailors, construction workers, skiers, hikers), populations living at low latitudes (tropical countries), high altitude (more intense UV), reflection off snow, water, and sand.
  • Wind and dust exposure: Chronic ocular surface irritation → conjunctival degeneration, particularly significant in arid and windy environments
  • Chronic dry eye Unstable tear film → prolonged exposure of the conjunctiva to irritants → accelerated degeneration
  • Age: increasing prevalence + rare before age 30 + very frequent after age 60 + accumulation of UV damage
  • Contact lenses: Prolonged wear → ocular surface irritation + dryness → can aggravate an existing pinguecula + poorly fitting rigid gas permeable lenses rub against the pinguecula
ℹ️ Pingueculae and pterygia share the same risk factors (UV, wind, dust) and the same basic pathophysiology (elastoid degeneration of the conjunctival stroma) – which has led some authors to consider them as two stages of the same pathological continuum, with pingueculae representing the early stage and pterygia the advanced stage with corneal invasion. However, pingueculae alone progress to pterygia in only a minority of cases. The fundamental clinical distinction remains simple: if the lesion affects the cornea, it's a pterygium → ophthalmic reference; if it remains on the conjunctiva without affecting the cornea, it's a pinguecula → conservative treatment.

Treatment

  • Simple observation if asymptomatic: Asymptomatic pterygium requires no treatment + explain to the patient the benign nature of the lesion + annual clinical monitoring or if the lesion changes
  • Artificial tears First-line treatment: If discomfort + foreign body sensation + dryness + preservative-free if frequent use (> 4 times/day) + instillation 3 to 6 times/day + lubricating gels at night if nocturnal dryness + artificial tears reduce irritation by stabilizing the tear film on the irregular surface of the pinguecula
  • Vasoconstrictor eye drops (decongestants): oxymetazoline + tetrahydrozoline → reduces conjunctival redness associated with pinguecula + occasional use only (maximum 3 to 4 consecutive days) → risk of rebound effect with chronic use + avoid if narrow-angle glaucoma or ocular hypertension
  • Topical NSAIDs + topical corticosteroids during pingueculitis flare-ups: ketorolac eye drops (Acular®) + diclofenac eye drops → effective for pain and inflammation + topical corticosteroids (fluorometholone 0.1 % - FML®) × 5 to 7 days → short-term treatment only → do not prolong without ophthalmological monitoring (risk of corticosteroid-induced ocular hypertension + cataracts)
  • UV Protection - An Essential Preventive Measure: sunglasses with UV-B protection (UV index 400 + 99–100% UV-A and UV-B protection) + wraparound glasses for intense exposure + wide-brimmed hat + avoid peak sun hours (10 a.m.–4 p.m.) + particularly important in patients with pinguecula to slow progression and prevent episodes of pingueculitis
  • Surgical excision: Rare indication + only if significant cosmetic concern not accepted by the patient + or interference with contact lens wear + or rapid growth requiring histological confirmation + conjunctival resection under local anesthesia + possible recurrence + scarring risk + cosmetic result sometimes less good than expected → thoroughly assess patient expectations
Ophthalmological consultation recommended

Consult an ophthalmologist if a yellowish or whitish conjunctival lesion appears to be progressively extending towards the cornea (crossing the limbus) — this is then likely a pterygium and not a pinguecula, requiring regular monitoring and potentially surgery if the visual axis is threatened. Also consult if the lesion rapidly changes in appearance, color, or size, or if it is irregular and vascularized — to rule out a neoplastic condition of the ocular surface.

For the differential diagnosis of a conjunctival lesion, prescribing artificial tears, managing pingueculitis episodes, and ophthalmological referral if necessary, Clinique Omicron offers medical consultations at its service points in Quebec and through telemedicine. To make an appointment, visit cliniqueomicron.ca.

Consult at Clinique Omicron

Clinique Omicron's Doctors and Nurse Practitioners (NPs) recognize pinguecula on eye examination, reassure the patient about the lesion's benign and non-progressive nature, prescribe artificial tears for discomfort, treat acute episodes of pingueculitis with topical NSAIDs or short-term topical corticosteroids, provide UV protection advice to prevent progression, and refer to ophthalmology if the diagnosis is uncertain or if the lesion progresses towards the cornea. Consultations are available at several service points in Quebec and via telemedicine. To book an appointment, visit cliniqueomicron.ca.

The content of this page is for informational purposes only and does not replace the advice of a doctor or ophthalmologist. Any conjunctival lesion that is atypical in appearance, rapidly growing, or invading the cornea should be evaluated by an ophthalmologist to rule out more serious pathology.

Omicron Clinic

Need to consult a doctor?

Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.

Insurance receipts. 7j/7. No family doctor required.

Skip to content